Transitional Cell Carcinoma of theRenal Pelvis and Its Expression ofp53 Protein, c-erbB-2 Protein,Neuron-Specific Enolase, Phe 5,Chromogranin, Laminin andCollagen Type IV
Bodil Bjerkehagen(Oslo University Hospital), Jahn M. Nesland(Oslo University Hospital), Ruth Holm(University of Aleppo), Nils Raabe(Norwegian Cancer Society), Sophie D. Fosså(Oslo University Hospital)
Cited by 22
Related Papers
5-Aminolevulinic acid-based photodynamic therapy
|Cancer|1997|976
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
|The Lancet|2008|873
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830
Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924
|Journal of Clinical Oncology|2001|628